# Multimodal Biomarkers of Electroconvulsive Therapy in Severe and Treatment-resistant Depression

> **NCT05463562** · — · UNKNOWN · sponsor: **Max-Planck-Institute of Psychiatry** · enrollment: 134 (estimated)

## Conditions studied

- Depressive Disorder
- Bipolar Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05463562
- **Lead sponsor:** Max-Planck-Institute of Psychiatry
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-24
- **Primary completion:** 2025-02-23
- **Final completion:** 2025-02-23
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2023-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05463562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05463562, "Multimodal Biomarkers of Electroconvulsive Therapy in Severe and Treatment-resistant Depression". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05463562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*